These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10511014)

  • 21. Strategies for pharmacologic treatment of high functioning autism and Asperger syndrome.
    Towbin KE
    Child Adolesc Psychiatr Clin N Am; 2003 Jan; 12(1):23-45. PubMed ID: 12512397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychopharmacological interventions in autism spectrum disorder.
    Accordino RE; Kidd C; Politte LC; Henry CA; McDougle CJ
    Expert Opin Pharmacother; 2016; 17(7):937-52. PubMed ID: 26891879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio.
    Aman MG; Lam KS; Collier-Crespin A
    J Autism Dev Disord; 2003 Oct; 33(5):527-34. PubMed ID: 14594332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychopharmacology in childhood disorders.
    Wiener JM
    Psychiatr Clin North Am; 1984 Dec; 7(4):831-43. PubMed ID: 6151651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical report on pharmacological treatment of autism].
    Thivierge J
    Sante Ment Que; 1998; 23(1):85-95. PubMed ID: 9775955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychopharmacotherapy of Attention Deficit-Hyperactivity Disorder in Children with Comorbid Conditions.
    Naguy A
    Pediatr Neurol; 2018 May; 82():7-12. PubMed ID: 29678368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The genetics of autism.
    Muhle R; Trentacoste SV; Rapin I
    Pediatrics; 2004 May; 113(5):e472-86. PubMed ID: 15121991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders.
    Soorya L; Kiarashi J; Hollander E
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):753-71, viii. PubMed ID: 18775368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychotropic medication use among children with autism spectrum disorders within the Simons Simplex Collection: are core features of autism spectrum disorder related?
    Mire SS; Nowell KP; Kubiszyn T; Goin-Kochel RP
    Autism; 2014 Nov; 18(8):933-42. PubMed ID: 24031086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolegomenon to the clinical prerequisite: psychopharmacology and the classification of mental disorders.
    Ban TA
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(5):527-80. PubMed ID: 2892227
    [No Abstract]   [Full Text] [Related]  

  • 31. Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States.
    Houghton R; Ong RC; Bolognani F
    Autism Res; 2017 Dec; 10(12):2037-2047. PubMed ID: 28963809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Also Topiramate might have some benefit in psychopharmacological treatment of autism.
    Niederhofer H
    Med Hypotheses; 2008; 70(2):455. PubMed ID: 17656029
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral famotidine: a potential treatment for children with autism.
    Linday LA
    Med Hypotheses; 1997 May; 48(5):381-6. PubMed ID: 9185122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment.
    Rojas DC
    J Neural Transm (Vienna); 2014 Aug; 121(8):891-905. PubMed ID: 24752754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy of autism spectrum disorders.
    Benvenuto A; Battan B; Porfirio MC; Curatolo P
    Brain Dev; 2013 Feb; 35(2):119-27. PubMed ID: 22541665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Child and adolescent psychopharmacology. Important developmental issues.
    Tosyali MC; Greenhill LL
    Pediatr Clin North Am; 1998 Oct; 45(5):1021-35, vii. PubMed ID: 9884673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical diagnosis of autism].
    Rodríguez-Barrionuevo AC; Rodríguez-Vives MA
    Rev Neurol; 2002 Feb; 34 Suppl 1():S72-7. PubMed ID: 12447794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychopharmacology of aggression in children and adolescents with primary neuropsychiatric disorders: a review of current and potentially promising treatment options.
    Nevels RM; Dehon EE; Alexander K; Gontkovsky ST
    Exp Clin Psychopharmacol; 2010 Apr; 18(2):184-201. PubMed ID: 20384430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential benefits and limits of psychopharmacological therapies in pervasive developmental disorders.
    Molteni M; Nobile M; Cattaneo D; Radice S; Clementi E
    Curr Clin Pharmacol; 2014; 9(4):365-76. PubMed ID: 24050744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Psychopharmacology of autism].
    Chabrol H; Bonnet D; Roge B
    Encephale; 1996; 22(3):197-203. PubMed ID: 8767048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.